<i>TP53</i> Is a Potential Target of Juglone Against Colorectal Cancer: Based on a Combination of Molecular Docking, Molecular Dynamics Simulation, and In Vitro Experiments

<i>TP53</i> Is a Potential Target of Juglone Against Colorectal Cancer: Based on a Combination of Molecular Docking, Molecular Dynamics Simulation, and In Vitro Experiments

Background: Colorectal cancer is the third most common cancer worldwide, accounting for about 10% of all cancer cases. There is an urgent need to improve treatment outcomes and survival rates for colorectal cancer. Juglone is an anthraquinone with anti-inflammatory, antiviral, and anti-cancer proper...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunting Deng, Yanan Zhang, Xinghai Chen, Weiming Wang, Jinhai Huo
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Current Issues in Molecular Biology
Subjects:
Juglone
colorectal cancer
molecular docking
cell experiments
p53 protein
molecular dynamics simulations
Online Access:https://www.mdpi.com/1467-3045/47/6/439
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items